Single-chain insulin would change dosage, production

(University of Houston) A researcher from the University of Houston has created a form of recombinant insulin that could potentially address some of the biggest concerns about the lifesaving drug, including its price. Now the University's Office of Technology Transfer and Innovation is looking for a company to co-develop the technology and complete testing and approval by the US Food and Drug Administration.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news